Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
1,195.191,204.711,221.691,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
638.56640.21645.32638.69
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
831.57840.48844.16834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
213.36213.36215.79212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
1,449.261,454.771,462.651,447.95
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
2,382.452,371.192,380.452,362.86
AVE:ASX
Avecho Biotechnology Ltd
A$0.011
0.00%
(0.00) 1D
Apr 29, 2:34:31 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AVE...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
44.45M
Avg. vol.
4.87M
Volume
26.75M
52-wk high
A$0.01
52-wk low
A$0.00
EPS
-A$0.00
Shares outstanding
3.67B
No. of employees
15
News stories
From sources across the web
About Avecho Biotechnology Ltd
CEOPaul Gavin Ph.D.
Employees15
Founded1992
Headquarters-
SectorPharmaceutical industry
Last report
Jan 28, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-/ -AUD
Revenue / Estimate
338.85K/ (- est.)AUD
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
280.04K
280.04K
338.85K
338.85K
Cost of goods sold
82.58K
82.58K
92.11K
92.11K
Cost of revenue
82.58K
82.58K
92.11K
92.11K
Research and development expenses
652.12K
652.12K
478.93K
478.93K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
849.01K
849.01K
441.76K
441.76K
Operating expense
1.50M
1.50M
920.69K
920.69K
Total operating expenses
1.58M
1.58M
1.01M
1.01M
Operating income
-1.30M
-1.30M
-673.96K
-673.96K
Other non operating income
-
-
-
-
EBT including unusual items
-1.34M
-1.34M
-870.33K
-870.33K
EBT excluding unusual items
-1.34M
-1.34M
-870.33K
-870.33K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.34M
-1.34M
-870.33K
-870.33K
Net profit margin
-477.79%
-477.79%
-256.85%
-256.85%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-34.30K
-34.30K
-196.38K
-196.38K
Net interest expenses
-34.30K
-34.30K
-196.38K
-196.38K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.27M
-1.27M
-639.62K
-639.62K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more